机构:[a]School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China[b]School of Basic Medical Sciences, Guiyang University of Chinese Medicine, Guiyang, Guizhou Province 550025, China[c]Guangzhou Orthopedic Trauma Hospital, Guangzhou, Guangdong Province 510045, China[d]Department of Internal Medicine, Affiliated Shenzhen Hospital to Guangzhou University of Chinese Medicine, Shenzhen 518003, China广州中医药大学深圳医院深圳市康宁医院深圳医学信息中心[e]School of Nursing Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China
This study was supported by the National Natural Science
Foundation of China (grant nos. 81072908, 81173377 and 81273962)
and the Guangdong Provincial Science & Technology Project (grant no.
2009B030801283).
第一作者机构:[a]School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China[b]School of Basic Medical Sciences, Guiyang University of Chinese Medicine, Guiyang, Guizhou Province 550025, China
共同第一作者:
通讯作者:
通讯机构:[a]School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510006, China[*1]No. 232, East Waihuan Road, Guangzhou Higher Education Mega Center, Panyu District, Guangzhou, Guangdong Province, China.
推荐引用方式(GB/T 7714):
Xia Liu,Qin Xu,Liyan Mei,et al.Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats.[J].INTERNATIONAL IMMUNOPHARMACOLOGY.2018,61:169-177.doi:10.1016/j.intimp.2018.05.032.
APA:
Xia Liu,Qin Xu,Liyan Mei,Hang Lei,Quan Wen...&Hui Li.(2018).Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats..INTERNATIONAL IMMUNOPHARMACOLOGY,61,
MLA:
Xia Liu,et al."Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats.".INTERNATIONAL IMMUNOPHARMACOLOGY 61.(2018):169-177